NEW YORK (GenomeWeb) – The GenomeWeb Index was flat month over month in February, as some stocks seemed to recover from steep losses in January while others fell on fourth quarter results.

The GenomeWeb Index performed roughly in line with the Dow Jones Industrial Average — which gained less than half a percent during the month. But it fared better than the Nasdaq, which fell a little more than 1 percent, and the Nasdaq Biotechnology Index, which finished the month nearly 5 percent lower.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.